6201 Penn Therapeutics CRS — Philadelphia, Pennsylvania

6201 Penn Therapeutics CRS is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

6201 Penn Therapeutics CRS has participated in 3 clinical trials.

Therapeutic areas: HIV-1 Infection, Hepatitis.

Sponsors: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections.

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 6201 Penn Therapeutics CRS?

6201 Penn Therapeutics CRS has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 6201 Penn Therapeutics CRS conducted?

6201 Penn Therapeutics CRS has 3 clinical trials on record. Their work covers HIV-1 Infection, Hepatitis.

Is 6201 Penn Therapeutics CRS accredited by Crixeo Health?

6201 Penn Therapeutics CRS has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 6201 Penn Therapeutics CRS?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.